These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2866386)

  • 21. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
    Lü TM; Yang SL; Wu WZ; Tan JM
    Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients.
    Barber WH; Mankin JA; Laskow DA; Deierhoi MH; Julian BA; Curtis JJ; Diethelm AG
    Transplantation; 1991 Jan; 51(1):70-5. PubMed ID: 1987708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of acute rejection of cadaveric renal allografts with rabbit antithymocyte globulin.
    Hoitsma AJ; Reekers P; Kreeftenberg JG; van Lier HJ; Capel PJ; Koene RA
    Transplantation; 1982 Jan; 33(1):12-6. PubMed ID: 7039017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antilymphocyte induction immunosuppression in the post-Minnesota anti-lymphocyte globulin era: incidence of renal dysfunction and delayed graft function. A single center experience.
    Malinow L; Walker J; Klassen D; Oldach D; Schweitzer E; Bartlett ST; Weir MR
    Clin Transplant; 1996 Jun; 10(3):237-42. PubMed ID: 8826659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and economic analysis of short-course versus standard-course antithymocyte globulin (rabbit) induction therapy in deceased-donor renal transplant recipients.
    Marfo K; Akalin E; Wang C; Lu A
    Am J Health Syst Pharm; 2011 Dec; 68(23):2276-82. PubMed ID: 22095818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal deletion using total lymphoid irradiation with no maintenance immunosuppression in renal allograft recipients.
    Trivedi HL; Kaneku H; Terasaki PI; Feroz A; Vanikar AV; Trivedi VB; Khemchandani SI; Dave SD; Modi PR; Jahr F; Idica A; Everly MJ
    Clin Transpl; 2009; ():265-80. PubMed ID: 20524291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administration of Antithymocyte Globulin (Rabbit) to Treat a Severe, Mixed Rejection Episode in a Pregnant Renal Transplant Recipient.
    Kutzler HL; Ye X; Rochon C; Martin ST
    Pharmacotherapy; 2016 Apr; 36(4):e18-22. PubMed ID: 26892892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Canine pancreas and kidney transplantation following total-lymphoid irradiation.
    Williamson P; Allen RD; Deane SA; Ekberg H; Grierson JM; Hawthorne WJ; Mears DC; Tiver K; Little JM; Stewart GJ
    Transplantation; 1990 Oct; 50(4):576-9. PubMed ID: 2219277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
    Clark G; Walsh G; Deshpande P; Koffman G
    Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.
    Kirklin JK; Bourge RC; White-Williams C; Naftel DC; Thomas FT; Thomas JM; Phillips MG
    J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression.
    Schwartz JJ; Ishitani MB; Weckwerth J; Morgenstern B; Milliner D; Stegall MD
    Transplantation; 2007 Sep; 84(6):715-21. PubMed ID: 17893604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination treatment of low dose Anti-Thymocyte Globulin (ATG), Rituximab and high dose Sirolimus as induction agents in immune-conditioned recipients.
    Ravichandran P; Natrajan T; Jaganathan R
    Int Immunopharmacol; 2006 Dec; 6(13-14):1973-6. PubMed ID: 17161350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose maintenance prednisone and antilymphoblast globulin for the treatment of acute rejection. A steroid-sparing approach to immunosuppressive therapy.
    Streem SB; Novick AC; Braun WE; Steinmuller D; Greenstreet R
    Transplantation; 1983 May; 35(5):420-4. PubMed ID: 6342219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pharmacoeconomic comparison of antithymocyte globulin and muromonab CD3 induction therapy in renal transplant recipients.
    Brennan DC; Schnitzler MA; Baty JD; Ceriotti CS; Lowell JA; Shenoy S; Howard TK; Woodward RS
    Pharmacoeconomics; 1997 Mar; 11(3):237-45. PubMed ID: 10165313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring.
    Cosimi AB; Wortis HH; Delmonico FL; Russell PS
    Surgery; 1976 Aug; 80(2):155-63. PubMed ID: 781887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group.
    Sinclair NR
    CMAJ; 1992 Sep; 147(5):645-57. PubMed ID: 1521210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved patient and graft survival after treatment of acute rejections of cadaveric renal allografts with rabbit antithymocyte globulin.
    Hoitsma AJ; van Lier HJ; Reekers P; Koene RA
    Transplantation; 1985 Mar; 39(3):274-9. PubMed ID: 3883593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
    Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
    N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One year results of preoperative single bolus ATG-Fresenius induction therapy in sensitized renal transplant recipients.
    Wang D; Chen JH; Wu WZ; Yang SL; Wu GJ; Wang H; Tan JM
    Transplant Proc; 2007; 39(1):69-72. PubMed ID: 17275476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fractionated total lymphoid irradiation as preparative immunosuppression in high risk renal transplantation: clinical and immunological studies.
    Najarian JS; Ferguson RM; Sutherland DE; Slavin S; Kim T; Kersey J; Simmons RS
    Ann Surg; 1982 Oct; 196(4):442-52. PubMed ID: 6812511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.